Adlux Medicity And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-07-2024
- Paid Up Capital ₹ 0.10 M
as on 31-07-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 47.32%
(FY 2023)
- Ebitda 47.32%
(FY 2023)
- Net Worth -7.52%
(FY 2023)
- Total Assets -90.00%
(FY 2023)
About Adlux Medicity And Research Centre
The Corporate was formerly known as Adlux International Convention And Exhibition Centre Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sudheesan Damodaran, Sujith Sudheesan, and Anjana Sudheesan serve as directors at the Company.
- CIN/LLPIN
U85100KL2012PTC032534
- Company No.
032534
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2012
- Date of AGM
14 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Adlux Medicity And Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudheesan Damodaran  | Managing Director | 03-Nov-2012 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujith Sudheesan | Director | 03-Nov-2012 | Current |
| Anjana Sudheesan | Director | 25-Jan-2019 | Current |
Financial Performance and Corporate Structure Insights of Adlux Medicity And Research Centre.
Adlux Medicity And Research Centre Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 47.32% increase in profit. The company's net worth dipped by a decrease of 7.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adlux Medicity And Research Centre?
In 2023, Adlux Medicity And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adlux Medicity And Convention Centre Private LimitedActive 22 years 26 daysSudheesan Damodaran, Sujith Sudheesan and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adlux Medicity And Research Centre?
Unlock and access historical data on people associated with Adlux Medicity And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adlux Medicity And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adlux Medicity And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
